ArticleMolecular therapy : the journal of the American Society of Gene Therapy2021

Targeting Telomerase with an HLA Class II-Restricted TCR for Cancer Immunotherapy.

Pierre Dillard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.